Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy

Completed · Phase 2 · Has a placebo group

Conditions studied: Bunionectomy, Orthopedic Surgery

In brief

To determine whether a single dose of intravenous lornoxicam is superior to intravenous placebo for management of post-operative pain in patients who have surgical removal of a bunion on the lower extremity. One-fourth of patients in this study will receive a single dose of intravenous ketorolac for management of pain and one-fourth of patients in this study will receive a single dose of an intravenous placebo.

Key facts

Study ID

NCT00293631

Run by

POZEN

People needed

100

Starts

2005-11-01

Expected to finish

2006-03-01

Last updated by the study team

2012-12-03

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who are scheduled for a primary unilateral first metatarsal bunionectomy under local anesthetic.
• Subjects have no contraindications to this surgery and have no allergies to the study medications or similar medications.
• Subjects are in generally good health with no uncontrolled chronic illnesses or diseases.

You may not qualify if…

• Subjects who are pregnant.
• Subjects who have significant obesity.
• Subjects with medically significant heart, liver, kidney, lung or endocrine disease.
• Subjects with active viral disease, i.e. hepatitis, HIV.

Where it is running

• Advanced Clinical Research Institute — Anaheim, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.